Discrimination of the heterogeneity of bone marrow‑derived dendritic cells
- Authors:
- Published online on: September 8, 2017 https://doi.org/10.3892/mmr.2017.7448
- Pages: 6787-6793
-
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Abstract
Introduction
Dendritic cells (DCs), which differentiate to highly competent antigen-presenting cells, are pivotal elements of immune response in processing and presenting antigens (1). DCs present immunogenic or tolerogenic effects in subsequent immune reactions according to their maturation and functional and molecular expression (2). The current method of DC generation is based on bone marrow (BM) culture and granulocyte-macrophage colony-stimulating factor (GM-CSF) supplementation, and is used worldwide. However, the DC lineage is complex due to the DC cell derivation and differentiation, and there are many similarities and diversities compared with other hematopoietic cells, including monocytes and macrophages (3,4).
A previous study has demonstrated that BM cells are able to differentiate to classical (or conventional) DCs (cDCs) in an in vitro mouse models (5). cDCs are considered the most important and distinct lineage for stimulating naive T cell activation (3), although the identification of other DC subsets, such as plasmacytoid DCs, Langerhans cells and monocyte-derived DCs, has markedly improved. However, cultured DCs have been demonstrated to be a heterogeneous group of cells resulting in variations in the usage of DCs (6,7). This heterogeneous state may be explained as follows: i) The source of DCs is highly variable, including from BM, peripheral blood mononuclear cells or monocytes, or from rodents or humans; and ii) DCs may be modulated by cultural environments and stimulating factors, and the differentiation of stem cells or progeny DCs is extremely complex, which results in numerous subsets. Another problem is that at the end of the culture process, different DC subsets are selected for subsequent experiments, including non-adherent mature DCs, all non-adherent cells, loosely adherent clusters, both non-adherent and loosely adherent cells or all cells (8–11). Several previous studies have not provided information on the DC subsets that were examined (12,13). This phenomenon reflects a widespread lack of information regarding the heterogeneity of cultured DCs, which has resulted in a lack of clear understanding of the findings related to their usage (14–16). Therefore, efforts are still required to optimize DC culture systems and to discriminate the heterogeneity of DC culture subsets.
In the present study, DCs were divided into three subsets: i) Non-adherent; ii) adherent; and iii) mixed. Cytokine secretion from progeny DCs and DCs was evaluated on culture days 3, 6 and 8. In addition, the maturation state of the three subsets in the presence of lipopolysaccharide (LPS) stimulation was detected. Accordingly, at the end of the culture process, mixed lymphocyte reaction (MLR) was used to analyze the ability of each subset to stimulate T cell proliferation by alloantigen presentation. This study provided a promising BM-derived DC culture system in regards to the quantity and quality of the final DC products. Notably, to the best of our knowledge, this was the first study to divide cultured DCs into three subsets to observe their heterogenic immunological properties based on their adherent status. These aspects may be emphasized in immunological investigations when using cultured DCs.
Materials and methods
Animals
The commonly used mouse strains C57BL/6 (H2b) (n=8) and BALB/c (H2d) (n=32) were used in the present study. A total of 40 male mice (age, 6–8 weeks; weight, 20±1 g) were obtained from Beijing HFK Bioscience Co. Ltd. (Beijing, China), and kept under specific pathogen-free conditions, at 25°C in 55% humidity and under 12-h light/dark cycles, with free access to food and water. All experiments in this protocol were approved by the Institutional Animal Care and Use Committee at Tongji Medical College, Huazhong University of Science and Technology (Wuhan, China).
Bone marrow preparation and DC culture system
Balb/c were euthanized and rinsed liberally in ethanol for 5 min. The hindlimbs were severed and the attached soft tissues were rubbed from the femurs and tibias with sterile gauze. Both ends of the epiphyses were cut from the marrow cavity and the marrow was flushed out with RPMI-1640 medium (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) into a dish. The medium was filtered through a 74-µm aperture nylon mesh to a 15 ml centrifuge tube in order to remove small pieces of bone and debris. The tube was centrifuged at 300 × g at room temperature for 5 min and the supernatant was discarded. Red blood cells were collected and lysed with 1 ml Red Blood Cell Lysis buffer (Beijing Solarbio Science & Technology Co., Ltd., Beijing, China) for 2 min to obtain BM-derived mononuclear cells (BMDMCs). A total of 5 ml RPMI-1640 medium containing 10% FBS was added to dilute the lysis buffer at room temperature and the mixture was centrifuged at 300 × g at room temperature for 5 min. Cells (1×106 cells/ml) were cultured (5% CO2, 37°C) in 10 ml fresh RPMI-1640 medium containing 10% FBS. Subsequently, recombinant murine (rm) GM-CSF (20 ng/ml) and rm-interleukin (IL)-4 (10 ng/ml; both from PeproTech, Inc., Rocky Hill, NJ, USA) were added and the culture dish was incubated in a humidified 5% CO2 incubator at 37°C.
Following 3 days incubation, the medium (including non-adherent cells) was aspirated and discarded. Fresh complete RPMI-640 medium (10 ml) containing rmGM-CSF (20 ng/ml) and rmIL-4 (10 ng/ml) was added and the cells were returned to the incubator. On day 6, the medium was collected, centrifuged at 300 × g at room temperature for 5 min, and the cell pellet was resuspended in 10 ml complete RPMI-1640 medium containing 20 ng/ml rmGM-CSF and 10 ng/ml rmIL-4. The resuspended cells (~2.5×106 cells) were returned to the incubator for further culture. On day 7, LPS (500 ng/ml; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) was added to the culture dish to stimulate DC maturation for 24 h, and on day 8, the different subsets of cultured cells were collected, as described below, for further investigation.
Isolation of different DC subsets
Cultured cells were divided according to their different adherent features: Non-adherent, loosely adherent, dislodgeable adherent and firmly adherent. Non-adherent cells were the cells floating in the medium following a gently swirling the dish. Loosely adherent cells were obtained following 3 min digestion with 0.25% trypsin-EDTA (Gibco; Thermo Fisher Scientific, Inc.) and gentle pipetting at 37°C. Dislodgeable adherent cells were defined as the cells that fell to the bottom of the culture dish following 0.25% trypsin-EDTA digestion for 5 min with vigorous pipetting at 37°C. Firmly adherent cells were the cells that remained on the wall following hard trypsin-EDTA digestion and vigorous pipetting, as have been confirmed as vacuolated macrophages, as previously described (17). In the present study, DCs were collected and analyzed in the following subsets: i) Non-adherent cells; ii) adherent cells, which comprised loosely adherent + dislodgeable adherent cells; and iii) mixed cells, which comprised non-adherent cells + adherent cells. As firmly adherent cells do not contribute to cDC population, they were not used in subsequent investigations. Cells were harvested, centrifuged at 300 × g for 5 min at room temperature and a single-subset suspension of the purified cells was prepared for further experiments.
Phenotypic analysis
To analyze phenotypic markers of the different DC subsets, the cells were stained in the dark at 4°C for 30 min with the following monoclonal antibodies from eBioscience (Thermo Fisher Scientific, Inc.): Allophycocyanin (APC)-conjugated anti-CD11c (cat no. 17-0114, 1:800), phycoerythrin (PE)/cyanine (Cy)5-conjugated anti-CD40 (cat no. 15-0401, 1:800), fluorescein isothiocyanate (FITC)-conjugated anti-CD80 (cat no. 11-0801, 1:2,000), PE/Cy5-conjugated anti-CD86 (cat no. 15-0862, 1:3,333); PE-conjugated anti-major histocompatibility complex class II (MHC-II; act no. 12-5321, 1:10,000), APC-conjugated anti-F4/80 (cat no. 17-4801, 1:100) and PE-conjugated anti-CD11b (cat no. 12-0118, 1:1). Corresponding isotype-matched irrelevant specificity controls were performed in parallel, using Armenian hamster immunoglobulin (Ig) G isotype control (cat no. 11-4888; eBioscience; Thermo Fisher Scientific, Inc.) in the same dilutions as the target antibodies. A total of 10,000 events were collected for each test by BD FACSCalibur flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA) and cells with large forward scattering and side scattering were analyzed by FlowJo software version 7.6 (FlowJo LLC, Ashland, OR, USA).
Cytokine profiling in different subsets of DCs
During the process of differentiation and maturation, progeny DCs and parent DCs develop the ability to secrete cytokines based on their heterogenic immunological features (18). To explore their immune function, cytokine secretion profiles were studied on day 3, 6 and 8. At each time point the adherent, non-adherent and mixed cells were harvested at a density of 7×106. Following 2 washes with PBS (Hyclone; GE Healthcare Life Sciences, Logan, UT, USA), the cells were seeded in a 100 mm plastic tissue culture dish in 10 ml complete RPMI-1640 medium for an overnight incubation at 37°C in a humidified atmosphere containing 5% CO2. Subsequently, the medium was collected to measure the levels of IL-2 (cat no. BMS601), IL-12p70 (cat no. BMS6004), interferon (IFN)-γ (cat no. BMS606), IL-4 (cat no. BMS613) and IL-10 (cat no. BMS614/2) production by sandwich ELISA kits (Platinum ELISA, all by eBioscience; Thermo Fisher Scientific, Inc.). Cytokine levels were measured as pg/ml and quantified by reference, according to the manufacturer's protocol.
CD3+ T cell isolation and culture
Male C57BL/6 (H2b) mice (n=8) were euthanized and their armpits, groin and mesenteric lymph nodes were harvested. The lymph nodes were placed in a 60×15 mm2 culture dish with 5 ml serum-free PBS. Lymph nodes were minced and the mixture was filtered through a 74-µm aperture nylon mesh to obtain allogeneic responder T lymphocytes. The freshly isolated lymphocytes were centrifuged for 5 min at 300 × g at room temperature and lymphocytes were purified using a Mouse CD3+ T Cell Enrichment Column (R&D Systems, Inc., Minneapolis, MN, USA) according to the manufacturer's protocol.
Allogeneic T cell activation
MLR was performed to measure the proliferative response of allogeneic T cells that were stimulated by the cultured DCs. On day 8 of incubation, the adherent cells, non-adherent cells and mixed cells were collected and served as stimulators, and the CD3+ T cells isolated from lymph nodes of allogeneic C57BL/6 mice served as responders. The responder T cells were 92% CD3+ cells, and were labeled with a carboxyfluorescein succinimidyl amino ester tracer at 37°C for 10 min (CFSE; 1 µmol/l in PBS; Invitrogen; Thermo Fisher Scientific, Inc.), as previously described (19). The labeling process was quenched by adding 800 µl FBS on ice for 5 min. The CFSE-labeled T cells were centrifuged at 300 × g at room temperature for 5 min. Stimulator DCs (non-adherent cells, adherent cells or mixed cells) at a density of 1×105 cells/well were co-cultured with CFSE-labeled T cells (5×105 cells/well) at a 1:5 ratio of DCs to T cells in 96-well rounded-bottom microtiter plates (Corning Inc., Corning, NY, USA) at a final volume of 200 µl of RPMI-1640 medium with 10% FBS, and incubated at 37°C for 4 days. CFSE-labeled T cells cultured alone served as the negative control. T cells treated with anti-mouse CD3e (cat no. 16-0031; 1:2,000, eBioscience, Thermo Fisher Scientific, Inc.) and anti-mouse CD28 (cat no. 16-0281; 1:2,000, eBioscience, Thermo Fisher Scientific, Inc.) antibodies served as positive controls. A total of 5 groups of cells (negative control, positive control, T cells co-cultured with non-adherent cells, T cells co-cultured with adherent cells and T cells co-cultured with mixed cells) were collected separately and centrifuged twice for 5 min at 300 × g at room temperature with 2 ml cold FACS buffer (PBS supplemented with 5% FBS and 0.05% NaN3). Cells were stained with APC-labeled anti-CD4 (cat no. 17-0042; 1:600, eBioscience, Thermo Fisher Scientific, Inc.) for 30 min at 4°C in the dark and analyzed by flow cytometry (FlowJo software version 7.6; FlowJo LLC, Ashland, OR, USA). MLR was evaluated as follows: i) CD4+ T cells gathering to the y-axis with clear proliferation stripes following stimulation, and presenting a strong proliferative response to the stimulator (20); ii) the proliferative index, which was defined as the sum of the cells in all generations divided by the calculated number of original cells (21); and iii) the cell division index, which was defined as the average number of divisions undertaken by all T cells in the parent generation (22).
Statistical analysis
Data are presented as the mean ± standard deviation. All experiments were conducted four to eight times. Repeated measures analysis of variance was used to assess the statistical significance of the differences between groups, and the Bonferroni method was used to correct for multiple comparisons. P<0.05 was considered to indicate a statistically significant difference. All statistical analyses were conducted with SPSS software, version 19.0 (IBM Corp., Armonk, NY, USA).
Results
F4/80 and CD11b expression on the cell surface classifies firmly adherent cells as macrophages
GM-CSF was able to generate populations of macrophages and DCs in cell culture. The expressions of F4/80 and CD11b on the cell surface were used as specific markers to identify macrophages. The percent of F4/80+CD11b+ cells in each group was 21.00±2.59% in the non-adherent cells, 38.17±0.97% in the adherent cells, 28.60±1.04% in the mixed cells and 98.20±0.46% in the firmly adherent cells (P<0.0001, firmly adherent cells vs. non-adherent cells, adherent cells and mixed cells; Fig. 1), which indicated that the firmly adherent cells consisted of macrophages. These results are consistent with those described by Inaba et al (17) in 1992, which demonstrated that macrophages firmly adhered to the culture vessel, expressed high levels of the F4/80 antigen expressed little or no MHC-II and exhibit no MLR-stimulating activity. Because the firmly adherent cells did not contribute to the population of cDCs, they were not used for further investigations.
Each DC subset displays different purity and maturation states
In order to clarify the purity of the three DC subsets, the remaining three BM-derived DC subsets were probed CD11c+ expression. Populations of the non-adherent, adherent and mixed cells were purified on day 8. CD11c+ expression analysis from the cultures revealed that all three DC subsets were able to expand in GM-CSF and IL-4 cultures, and generated various levels of CD11c+ cells (Fig. 2): 95.43±1.57% for the non-adherent cells (P<0.001 vs. adherent cells; P=0.0046 vs. mixed cells); 64.20±6.18% for the adherent cells; and 81.43±6.59% for the mixed cells (P=0.0026 vs. adherent cells). On day 8, the maturation phenotype of three subsets was analyzed following LPS stimulation. The graphs in Fig. 3A and B demonstrate that the adherent cells expressed the lowest level of CD11c+CD40+, CD11c+CD80+, CD11c+CD86+ and CD11c+MHC-II+ compared with the non-adherent cells and mixed cells, which indicated their ability to induce immune tolerance or suppression. Conversely, the non-adherent cells displayed the highest expression levels of the costimulatory molecules, which indicated that the cultured DC population was homogeneous and that DCs with different degrees of adhesion may have different maturation status.
Each DC subset exhibits different cytokine secretion levels throughout the DC culture process
Protein expression levels of the secreted cytokines IL-2, IL-12p70, IFN-γ, IL-4 and IL-10 in the three subsets were examined on days 3, 6 and 8 (Fig. 4). In addition to IL-4 and IL-12 p70, the expression of IL-2, IL-10 and IFN-γ in non-adherent cells, adherent cells and mixed cells was not significantly different between days 3, 6 and 8. Notably, the cytokine secretion profiles revealed the heterogeneity of the cultured DCs: IL-4 expression from day 6 appeared to increase in the non-adherent cells, whereas it appeared to decrease in the adherent and mixed cells, indicating that DC polarization occurred and the DC reservoir was not homogenous. On day 8, the non-adherent cells secreted high levels of both T helper (Th)1-type (IL-12p70) and Th2-type (IL-4) cytokines, which indicated that the non-adherent DCs themselves were not homogenous. Furthermore, following day 6, the curves of the cytokine secretion profiles for IFN-γ, IL-12 p70 and IL-10 in the three DC subsets became steeper, suggesting rapid development of the immune function of DCs. Therefore, day 6 may be a pivotal time point in which to modulate the immunological characteristics of the cultured DCs.
Each DC subset exhibits a different immunological reaction
The antigen-presenting ability of each DC subset was examined by MLR. Allogeneic T lymphocytes were stained with CFSE and cultured alone (negative control), with anti-mouse CD3e and anti-mouse CD28 (positive control groups), with non-adherent cells, with adherent cells and with mixed cells. After 4 days of incubation, cells were harvested and stained with anti-CD4 prior to analysis by flow cytometry. As presented in Fig. 5A, a bivariate dot-plot of CD4 expression and the level of CFSE fluorescence demonstrated that the non-adherent cells-treated T cells had undergone division and gathered on the y-axis, indicating high proliferation (red frame). The adherent cells-treated T cells exhibited limited division. The mixed cells-treated T cells demonstrated partial division. The proliferative index of the gated CD4+ T cells by stimulation of non-adherent cells, adherent cells and mixed cells was 1.69±0.33, 1.29±0.09 and 1.30±0.10, respectively, whereas the index of the negative and positive controls was 1.22±0.24 and 1.67±0.05, respectively. The cell division index of the gated CD4+ T cells of non-adherent cells, adherent cells and mixed cells was 0.33±0.21, 0.16±0.02 and 0.11±0.04, respectively, while the index of the negative and positive controls was 0.13±0.10 and 0.75±0.27, respectively (Fig. 5B). The MLR results demonstrated that the non-adherent DCs exhibited an strong ability to stimulate allogeneic T cell proliferation, whereas the ability of adherent DCs to stimulate T cell proliferation was weak.
Discussion
Heterogeneity of the DC subsets emerges from the first day during the culture process, owing to complicated DC differentiation (23). Previous studies have reportedly observed the presence of: i) BM non-adherent MHC-II− progenitors attaching to the stroma or plastic; ii) growing aggregates arising from firmly adherent MHC-II+ DCs; iii) mature, proliferating MHC-II+ DCs being released by the loosely attached aggregate; and iv) non-proliferating, non-adherent MHC-II+ DCs suspended in the medium, much like many of the DCs released from the spleen (17,24). During the permanent differentiation process from BM cells and progeny DCs to mature DCs, the cultured cells dynamically expressed a specific molecular form and immunological function (25), which resulted in the co-existence of various subsets of DCs (26). To accurately understand the DC reservoir, the immunological identification of DC subsets is required. To achieve a certain immunological aim, the investigators should select the corresponding cultured subset from the DC reservoir based on its maturity status and immunological features. For example, for anti-tumor or infectious effects, the mature subset should be used to prime T cells (27–29), for tolerance induction or immunosuppressive effects, the immature DCs should be used (30) and to check the effects of immune modulation therapy administered in vivo, mixed cultured DCs should first be tested in vitro (31). Unfortunately, the differences between the cultured subsets have been largely ignored, leading to confusion.
In the present study, the three DC subsets were distinguished from macrophages by detecting the expression of F4/80 and CD11b. CD11c was used to detect the different purity of non-adherent cells, adherent cells and mixed cells. CD40, CD80, CD86 and MHC-II were used to detect the different maturation state of non-adherent cells, adherent cells and mixed cells. The present results demonstrated that the adherent cells expressed the lowest levels of CD11c+CD40+, CD11c+CD80+, CD11c+CD86+ and CD11c+MHC-II+ compared with the non-adherent cells and mixed cells. The non-adherent cells displayed the highest expression levels of the costimulatory molecules, which indicated that the cultured DC population was homogeneous.
Given that the discrimination of DC subsets practically depends on their adherent status, the cells used in the present study were segregated as non-adherent, adherent, and mixed. The heterogeneity of the cultured DCs was determined using phenotypic markers and kinetic analysis of cytokine secretion in response to LPS and MLR stimulation. Continuous IL-2 secretion by the three subsets throughout the culture process indicated that the cultured DCs were functional and that the culture strategy was promising. The present study also demonstrated DC polarization through the differences in expression of IL-4 in the adherent and non-adherent cells. However, the non-adherent cells secreted high levels of both Th1-type cytokines and Th2-type cytokines on day 8, and the different secretory function, for IFN-γ, IL-12 p70 and IL-10, of the adherent cells and non-adherent cells developed rapidly from day 6. Furthermore, the non-adherent cells appeared to acquire mature features, whereas the adherent cells exhibited immature features based on their Th1-type and Th2-type cytokine secretion and ability to stimulate allogeneic T cell proliferation. MLR results revealed that non-adherent cells could stimulate the proliferation and division of allogeneic T lymphocytes, whereas the ability of adherent DCs to stimulate T cell proliferation was limited. The mixed cells were demonstrated to partially stimulate the proliferation and division of T cells. These data indicated that at the end of DC differentiation and proliferation, the cultured DC reservoir possessed heterogeneity, and non-adherent cells were not homogenous.
Limitations of the present study included the small sample size and the lack of assessments of cell viability and apoptosis within the experimental groups; further studies are required to address these issues. In conclusion, the present study discriminated cultured DCs as subsets of non-adherent, adherent and mixed cells, and identified their heterogeneous immunological features. The findings may enhance the knowledge of DC culture techniques and promote DC research in a more precise manner.
Acknowledgements
This work was supported by grants from The National Natural Science Foundation of China (grant nos. 81570678 and 81373169 to Nianqiao Gong and Jun Yang, respectively), the National High-Tech Researching and Developing Program (Program 863) of Ministry of Science and Technology of China (grant no. 2012AA021010 to Changsheng Ming) and the Clinical Research Physician Program of Tongji Medical College, HUST (to Nianqiao Gong).
References
Banchereau J and Steinman RM: Dendritic cells and the control of immunity. Nature. 392:245–252. 1998. View Article : Google Scholar : PubMed/NCBI | |
Wang J, Zhao LB, Chang S, Ming CS, Yang J and Gong NQ: Dynamic changes of phenotypes and secretory functions during the differentiation of pre-DCs to mature DCs. J Huazhong Univ Sci Technolog Med Sci. 37:191–196. 2017.PubMed/NCBI | |
Satpathy AT, Wu X, Albring JC and Murphy KM: Re(de)fining the dendritic cell lineage. Nat Immunol. 13:1145–1154. 2012. View Article : Google Scholar : PubMed/NCBI | |
Cortez-Retamozo V, Etzrodt M and Pittet MJ: Regulation of macrophage and dendritic cell responses by their lineage precursors. J Innate Immun. 4:411–423. 2012. View Article : Google Scholar : PubMed/NCBI | |
Merad M, Sathe P, Helft J, Miller J and Mortha A: The dendritic cell lineage: Ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol. 31:563–604. 2013. View Article : Google Scholar : PubMed/NCBI | |
Shurin MR, Pandharipande PP, Zorina TD, Haluszczak C, Subbotin VM, Hunter O, Brumfield A, Storkus WJ, Maraskovsky E and Lotze MT: FLT3 ligand induces the generation of functionally active dendritic cells in mice. Cell Immunol. 179:174–184. 1997. View Article : Google Scholar : PubMed/NCBI | |
Naik SH, Proietto AI, Wilson NS, Dakic A, Schnorrer P, Fuchsberger M, Lahoud MH, O'Keeffe M, Shao QX, Chen WF, et al: Cutting edge: Generation of splenic CD8+ and CD8+ dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J Immunol. 174:6592–6597. 2005. View Article : Google Scholar : PubMed/NCBI | |
Yi HJ and Lu GX: Adherent and non-adherent dendritic cells are equivalently qualified in GM-CSF, IL-4 and TNF-α culture system. Cell Immunol. 277:44–48. 2012. View Article : Google Scholar : PubMed/NCBI | |
Kalantari T, Kamali-Sarvestani E, Zhang GX, Safavi F, Lauretti E, Khedmati ME and Rostami A: Generation of large numbers of highly purified dendritic cells from bone marrow progenitor cells after co-culture with syngeneic murine splenocytes. Exp Mol Pathol. 94:336–342. 2013. View Article : Google Scholar : PubMed/NCBI | |
Delirezh N and Shojaeefar E: Phenotypic and functional comparison between flask adherent and magnetic activated cell sorted monocytes derived dendritic cells. Iran J Immunol. 9:98–108. 2012.PubMed/NCBI | |
Abdi K, Singh NJ and Matzinger P: Lipopolysaccharide-activated dendritic cells: ‘Exhausted’ or alert and waiting? J Immunol. 188:5981–5989. 2012. View Article : Google Scholar : PubMed/NCBI | |
Kushwah R, Wu J, Oliver JR, Jiang G, Zhang J, Siminovitch KA and Hu J: Uptake of apoptotic DC converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ Treg. Eur J Immunol. 40:1022–1035. 2010. View Article : Google Scholar : PubMed/NCBI | |
Pantel A, Teixeira A, Haddad E, Wood EG, Steinman RM and Longhi MP: Direct type I IFN but not MDA5/TLR3 activation of dendritic cells is required for maturation and metabolic shift to glycolysis after poly IC stimulation. PLoS Biol. 12:e10017592014. View Article : Google Scholar : PubMed/NCBI | |
Wang Y, Cao Y, Meng Y, You Z, Liu X and Liu Z: The novel role of thymopentin in induction of maturation of bone marrow dendritic cells (BMDCs). Int Immunopharmacol. 21:255–260. 2014. View Article : Google Scholar : PubMed/NCBI | |
Li R, Zheng X, Popov I, Zhang X, Wang H, Suzuki M, Necochea-Campion RD, French PW, Chen D, Siu L, et al: Gene silencing of IL-12 in dendritic cells inhibits autoimmune arthritis. J Transl Med. 10:192012. View Article : Google Scholar : PubMed/NCBI | |
Song Q, Meng Y, Wang Y, Li M, Zhang J, Xin S, Wang L and Shan F: Maturation inside and outside bone marrow dendritic cells (BMDCs) modulated by interferon-α (IFN-α). Int Immunopharmacol. 17:843–849. 2013. View Article : Google Scholar : PubMed/NCBI | |
Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S and Steinman RM: Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med. 176:1693–1702. 1992. View Article : Google Scholar : PubMed/NCBI | |
Schmid MA, Kingston D, Boddupalli S and Manz MG: Instructive cytokine signals in dendritic cell lineage commitment. Immunol Rev. 234:32–44. 2010. View Article : Google Scholar : PubMed/NCBI | |
Kunieda Y, Tamura Y, Sasaki H, Kurokawa Y, Miyagishima T, Ohae Y, Hige S, Gotohda Y, Tanaka J, Higuchi A, et al: Carcinoid of the papilla of Vater-somatostatinoma-a case report. Gan No Rinsho. 32:831–836. 1986.(In Japanese). PubMed/NCBI | |
Sela U, Olds P, Park A, Schlesinger SJ and Steinman RM: Dendritic cells induce antigen-specific regulatory T cells that prevent graft versus host disease and persist in mice. J Exp Med. 208:2489–2496. 2011. View Article : Google Scholar : PubMed/NCBI | |
Lyons AB and Parish CR: Determination of lymphocyte division by flow cytometry. J Immunol Methods. 171:131–137. 1994. View Article : Google Scholar : PubMed/NCBI | |
Pinto LA, Galvão Castro B, Soares MB and Grassi MF: An evaluation of the spontaneous proliferation of peripheral blood mononuclear cells in HTLV-1-infected individuals using flow cytometry. ISRN Oncol. 2011:3267192011.PubMed/NCBI | |
Haniffa M, Collin M and Ginhoux F: Ontogeny and functional specialization of dendritic cells in human and mouse. Adv Immunol. 120:1–49. 2013. View Article : Google Scholar : PubMed/NCBI | |
Steinman RM and Cohn ZA: Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med. 137:1142–1162. 1973. View Article : Google Scholar : PubMed/NCBI | |
Lutz MB, Kukutsch N, Ogilvie AL, Rössner S, Koch F, Romani N and Schuler G: An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods. 223:77–92. 1999. View Article : Google Scholar : PubMed/NCBI | |
Merad M and Manz MG: Dendritic cell homeostasis. Blood. 113:3418–3427. 2009. View Article : Google Scholar : PubMed/NCBI | |
Weigel BJ, Nath N, Taylor PA, Panoskaltsis-Mortari A, Chen W, Krieg AM, Brasel K and Blazar BR: Comparative analysis of murine marrow-derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses. Blood. 100:4169–4176. 2002. View Article : Google Scholar : PubMed/NCBI | |
Dudek AM, Martin S, Garg AD and Agostinis P: Immature, Semi-Mature, and fully mature dendritic cells: Toward a DC-cancer cells interface that augments anticancer immunity. Front Immunol. 4:4382013. View Article : Google Scholar : PubMed/NCBI | |
Strome SE, Voss S, Wilcox R, Wakefield TL, Tamada K, Flies D, Chapoval A, Lu J, Kasperbauer JL, Padley D, et al: Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Cancer Res. 62:1884–1889. 2002.PubMed/NCBI | |
Beriou G, Moreau A and Cuturi MC: Tolerogenic dendritic cells: Applications for solid organ transplantation. Curr Opin Organ Transplant. 17:42–47. 2012. View Article : Google Scholar : PubMed/NCBI | |
Kim SJ and Diamond B: Modulation of tolerogenic dendritic cells and autoimmunity. Semin Cell Dev Biol. 41:49–58. 2015. View Article : Google Scholar : PubMed/NCBI |